Product Code: ETC8851365 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The shingles vaccine market in the Philippines is growing as the government and private healthcare providers promote immunization programs. The increasing geriatric population and awareness of shingles-related complications are driving demand. The availability of recombinant and live-attenuated vaccines enhances treatment options. However, vaccine affordability and distribution logistics remain key challenges.
The demand for shingles vaccines in the Philippines is increasing as public health campaigns emphasize preventive healthcare. The growing geriatric population and government vaccination programs are contributing to higher vaccine adoption. The market is also benefiting from advancements in vaccine efficacy and availability.
The shingles vaccine market struggles with low vaccination rates, affordability issues, and distribution challenges. Public awareness about the availability and benefits of the shingles vaccine is low, leading to underutilization. The cost of vaccination is relatively high, making it difficult for a significant portion of the population to afford. Additionally, vaccine distribution is inconsistent, with rural healthcare facilities facing difficulties in maintaining proper cold storage.
With increasing awareness of preventive healthcare, the demand for shingles vaccines is expected to grow in the Philippines. Investors can enter this market by partnering with vaccine manufacturers, setting up immunization programs, and collaborating with healthcare providers to enhance vaccine accessibility.
Vaccination programs include shingles immunization for at-risk populations, particularly the elderly. The government provides subsidies for vaccines, while the FDA regulates safety and efficacy. Public awareness campaigns educate citizens on the benefits of vaccination.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Shingles Vaccine Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Shingles Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Shingles Vaccine Market - Industry Life Cycle |
3.4 Philippines Shingles Vaccine Market - Porter's Five Forces |
3.5 Philippines Shingles Vaccine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Philippines Shingles Vaccine Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
4 Philippines Shingles Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing shingles |
4.2.2 Rising geriatric population in the Philippines |
4.2.3 Government initiatives to promote immunization programs |
4.3 Market Restraints |
4.3.1 Limited accessibility to healthcare facilities in rural areas |
4.3.2 High cost of shingles vaccines |
4.3.3 Lack of education and understanding about shingles and vaccination |
5 Philippines Shingles Vaccine Market Trends |
6 Philippines Shingles Vaccine Market, By Types |
6.1 Philippines Shingles Vaccine Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Philippines Shingles Vaccine Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Philippines Shingles Vaccine Market Revenues & Volume, By Shingrix, 2021- 2031F |
6.1.4 Philippines Shingles Vaccine Market Revenues & Volume, By Zostavax, 2021- 2031F |
6.1.5 Philippines Shingles Vaccine Market Revenues & Volume, By SKYZoster, 2021- 2031F |
6.2 Philippines Shingles Vaccine Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Philippines Shingles Vaccine Market Revenues & Volume, By Recombinant Vaccine, 2021- 2031F |
6.2.3 Philippines Shingles Vaccine Market Revenues & Volume, By Live Attenuated Vaccine, 2021- 2031F |
7 Philippines Shingles Vaccine Market Import-Export Trade Statistics |
7.1 Philippines Shingles Vaccine Market Export to Major Countries |
7.2 Philippines Shingles Vaccine Market Imports from Major Countries |
8 Philippines Shingles Vaccine Market Key Performance Indicators |
8.1 Number of vaccination campaigns conducted by the government |
8.2 Percentage of population vaccinated against shingles |
8.3 Rate of reported shingles cases in the Philippines |
8.4 Number of healthcare facilities offering shingles vaccination services |
8.5 Level of public awareness about shingles and its prevention through vaccination |
9 Philippines Shingles Vaccine Market - Opportunity Assessment |
9.1 Philippines Shingles Vaccine Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Philippines Shingles Vaccine Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10 Philippines Shingles Vaccine Market - Competitive Landscape |
10.1 Philippines Shingles Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Philippines Shingles Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |